Directory of Stock Market Company
This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.
Search into NYSE and TSX
by quote, company name or key word
ARWR - Arrowhead Research Corp
Arrowhead Research Corporation (Arrowhead), incorporated in 1989, is a development-stage company. Arrowhead is a nanomedicine company engaged in development therapeutic products at the interface of biology and nano-engineering to cure disease and improve human health. Arrowhead is focused on the preclinical and clinical development of therapeutics for the treatment of cancer ","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"
Arrowhead Research Corp News
ARROWHEAD RESEARCH CORP : Arrowhead Presents Data on DPC System at TIDES 2012
4-traders - 7 hours ago
4-traders - 7 hours ago
PASADENA, California, May 22, 2012 - Arrowhead Research Corporation (NASDAQ:ARWR) today announced that Darren Wakefield, Ph.D., one of its Senior Scientists at its Madison, WI research and development facility presented data at the TIDES: ...
Shining a Light on Forgotten Obesity Drug Stocks Arrowhead Research (ARWR ...
SmallCap Network - May 17, 2012
SmallCap Network - May 17, 2012
A look at small cap stocks Arrowhead Research (ARWR), EnteroMedics (ETRM) and PROLOR Biotech (PBTH) that are also developing obesity treatments.
Biogen Announces US and EU Authorities Accept Oral BG-12 Marketing ...
Proactive Investors USA & Canada - May 10, 2012
Proactive Investors USA & Canada - May 10, 2012
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 9, 2012. Biogen Idec (NASDAQ: BIIB) announced that US and EU regulatory authorities have accepted the company's marketing applications for the review ...
Biogen Announces US and EU Authorities Accept Oral BG-12 Marketing ...
BioMedReports (subscription) - May 10, 2012
BioMedReports (subscription) - May 10, 2012
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 9, 2012.
Arrowhead Reports Fiscal 2012 Second Quarter Financial Results
TheStreet.com (press release) - May 9, 2012
TheStreet.com (press release) - May 9, 2012
By Business Wire 05/08/12 - 04:01 PM EDT Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in RNA therapeutics and obesity, today announced financial results for its fiscal 2012 second quarter ended March ...
Arrowhead Presents Data on DPC System and Hepatitis B Program at CLINAM 2012
MarketWatch (press release) - May 9, 2012
MarketWatch (press release) - May 9, 2012
PASADENA, Calif., May 09, 2012 (BUSINESS WIRE) -- Arrowhead Research Corporation (UTD:ARWR) today announced that David Lewis, Ph.D.
Arrowhead Reports Fiscal 2012 Second Quarter Financial Results
MarketWatch (press release) - May 8, 2012
MarketWatch (press release) - May 8, 2012
PASADENA, Calif., May 08, 2012 (BUSINESS WIRE) -- Arrowhead Research Corporation (UTD:ARWR) , a nanomedicine company with development programs in RNA therapeutics and obesity, today announced financial results for its fiscal 2012 second quarter ended ...
Alexza Receives Response Letter for Adasuve; Oxygen Secures Clinical Supply of ...
BioMedReports (subscription) - May 3, 2012
BioMedReports (subscription) - May 3, 2012
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 2, 2012.
Arrowhead to Present at Series of Upcoming Scientific Conferences
MarketWatch (press release) - May 3, 2012
MarketWatch (press release) - May 3, 2012
PASADENA, Calif., May 03, 2012 (BUSINESS WIRE) -- Arrowhead Research Corporation (UTD:ARWR) today announced that senior management will present data for its Dynamic PolyConjugate(TM) (DPC) delivery platform for siRNA delivery including its RNAi ...
Arrowhead to Report Fiscal 2012 Second Quarter Financial Results
EON: Enhanced Online News (press release) - May 2, 2012
EON: Enhanced Online News (press release) - May 2, 2012
PASADENA, Calif.--(EON: Enhanced Online News)--Arrowhead Research Corporation (NASDAQ:ARWR) today announced that it will report its financial results for the fiscal 2012 second quarter ended March 31, 2012, on Tuesday, May 8, 2012 at 4:30 pm Eastern ...
NYSE Media Coverage Selection of the best articles found in your favorit medias